We aimed to evaluate if combining serial examination of urine sediment to renal cell damage (KIM-1) and arrest (TIMP-2, IGFBP7) biomarkers could improve the prediction of progression and mortality of SA-AKI. The gene discussed is TIMP2; the disease is acute kidney injury.